Table 1 |
|||||
|
Histological scoring of synovitis and cartilage damage in the tarsal joints from HLA-B27 transgenic rats |
|||||
|
Group |
Synovial structure (0–3) |
Fibroplasia (0–3) |
Inflammatory cells (0–3) |
Pannus (0–2) |
Total synovitis score (0–11) |
|
|
|||||
|
T/MC vehicle |
3.00 ± 0.00 |
2.80 ± 0.45 |
3.00 ± 0.00 |
1.60 ± 0.89 |
10.40 ± 1.34 |
|
WAY-169916, 10 mg/kg |
1.80 ± 0.45* |
1.20 ± 0.84* |
1.40 ± 0.55*† |
0.40 ± 0.89 |
5.00 ± 2.24*† |
|
Prednisolone, 0.6 mg/kg |
2.40 ± 0.55 |
2.00 ± 0.71* |
2.00 ± 0.00* |
1.60 ± 0.89 |
8.00 ± 1.87 |
|
|
|||||
|
Group |
Cartilage structure (0–6) |
Cartilage cells |
Safranin-O/Fast Green staining (0–4) |
Tidemark integrity (0–2) |
Total Mankin score |
|
|
|||||
|
T/MC vehicle |
3.80 ± 0.84 |
2.80 ± 0.45 |
3.20 ± 0.45 |
0 |
9.80 ± 1.48 |
|
WAY-169916, 10 mg/kg |
2.20 ± 0.45*† |
2.00 ± 0.45*† |
1.60 ± 0.55*† |
0 |
5.80 ± 0.84*† |
|
Prednisolone, 0.6 mg/kg |
3.40 ± 0.55 |
2.20 ± 0.45* |
3.00 ± 0.00 |
0 |
8.60 ± 0.89 |
|
|
|||||
|
Results are means ± SD. *Significantly less than vehicle (P < 0.005). †Significantly less than prednisolone (P < 0.005). |
|||||
|
Keith et al. Arthritis Research & Therapy 2005 7:R427 doi:10.1186/ar1692 |
|||||